L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model

Epithelial ovarian cancer (EOC) is the fifth most common cancer affecting the female population. At present, different targeted treatment approaches may improve currently employed therapies leading either to the delay of tumor recurrence or to disease stabilization. In this study we show that syndec...

Descripción completa

Detalles Bibliográficos
Autores principales: Orecchia, Paola, Balza, Enrica, Pietra, Gabriella, Conte, Romana, Bizzarri, Nicolò, Ferrero, Simone, Mingari, Maria Cristina, Carnemolla, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769537/
https://www.ncbi.nlm.nih.gov/pubmed/31443604
http://dx.doi.org/10.3390/cancers11091232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769537/
https://www.ncbi.nlm.nih.gov/pubmed/31443604
http://dx.doi.org/10.3390/cancers11091232

Ejemplares similares